All News
STAT+: Trump’s FDA navigates layoffs, exits, and a new hire
This week in health care politics and policy: FDA rehires staff, former drug regulator joins Pfizer, and NIH payments cap paused.
Read MoreSlashing Medicaid to Pay for Trump’s Tax Cuts Could Lead to Vast State Shortfalls
Republicans have proposed lowering the federal share of costs for Medicaid expansions, which could reshape the program by gutting one of the Affordable Care Act’s major provisions.
Read MoreWins for bulk milk testing and deafness research
In today's Morning Rounds newsletter, wins for bulk milk testing and deafness research, UnitedHealth takes on its critics, and more.
Read MoreMystery Illness Kills 50; CDC Discusses New Bat Coronavirus; Pope Shows Improvement
(MedPage Today) -- Note that some links may require registration or subscription. MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts.
Read MoreSTAT+: Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more
Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells
Read MoreHHS Tells Staffers They Can Ignore DOGE's 'Justify Your Job' Email
(MedPage Today) -- After a Saturday email from the Trump administration's Department of Government Efficiency (DOGE) team sparked anxiety among federal healthcare workers, HHS advised late on Monday
Read More90 deaths at hospital in Brighton being investigated as possible manslaughter
Exclusive: Police seek more resources as number of allegedly suspicious deaths at Royal Sussex County hospital more than doublesThe number of patient deaths being investigated as possible manslaughter
Read MoreBrewing tea removes heavy metals from water, study finds
Scientists say consumption of the beverage may have health benefit by reducing intake of metals such as lead The medicinal effect of a cup of tea is no surprise to anybody who has headed straight to t
Read MoreSTAT+: Eli Lilly to lower price of Zepbound vials, offer more doses
Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells.
Read More